(Q38630631)

4 September 2017

Determination of who may derive most benefit from aspirin in primary prevention: subgroup results from a randomised controlled trial (English)

1 reference

4 September 2017

1 reference

T W Meade

1

1 reference

4 September 2017

P J Brennan

series ordinal

2

1 reference

4 September 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

4 September 2017

1 reference

4 September 2017

321

1 reference

4 September 2017

7252

1 reference

4 September 2017

13-17

1 reference

British Hypertension Society guidelines for hypertension management 1999: summary

4 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27417

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27417

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27417

Final report on the aspirin component of the ongoing Physicians' Health Study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27417

Prophylactic aspirin and risk of peptic ulcer bleeding

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27417

Randomized controlled trial of low dose warfarin in the primary prevention of ischaemic heart disease in men at high risk: design and pilot study.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27417

Extra-cranial bleeding and other symptoms due to low dose aspirin and low intensity oral anticoagulation.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27417

Coronary heart disease case fatality in four countries. A community study. The Acute Myocardial Infarction Register Teams of Auckland, Augsburg, Bremen, FINMONICA, Newcastle, and Perth

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27417

Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study

31 August 2018

1 reference

12 December 2020

Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy

1 reference

12 December 2020

Does aspirin consumption affect the presentation or severity of acute myocardial infarction?

1 reference

12 December 2020

Previous aspirin use may attenuate the severity of the manifestation of acute ischemic syndromes

1 reference

12 December 2020

Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Res

1 reference

12 December 2020

Antithrombotic agents in coronary artery disease

1 reference

12 December 2020

Individualizing aspirin therapy for prevention of cardiovascular events

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.321.7252.13

1 reference

4 September 2017

1 reference

4 September 2017

PubMed publication ID

10875825

1 reference